导师姓名

徐丁

导师性别

男

职务职称

副主任医师

所在院系

上海交通大学医学院

一级学科

临床医学

二级学科

外科学

研究方向

前列腺疾病，膀胱肿瘤

联系电话

13774445969

电子邮箱

xuding@xinhuamed.com.cn

个人简介

2018-2019年前往德国Diakonie Klinikum 学习机器人手术及盆底手术，擅长泌尿系肿瘤，特别是膀胱癌、输尿管癌、肾盂癌的全程管理与微创治疗；擅长前列腺增生、慢性前列腺炎、尿失禁、尿频尿急排尿困难等各类排尿障碍疾病的诊治。主持国家自然科学基金1项，发表SCI论文十余篇。

学习与工作经历

2005-09 至 2013-06, 上海交通大学医学院, 临床医学, 博士

2013-07 至 2017-06, 上海交通大学医学院附属新华医院, 泌尿外科, 医师

2017-07 至 2021-12, 上海交通大学医学院附属新华医院, 泌尿外科, 主治医师

2022-01 至 今, 上海交通大学医学院附属新华医院, 泌尿外科, 副主任医师

科研工作与成果

主持国家自然科学基金青年项目1项，曾入选上海市科委,青年科技英才扬帆计划

以第一作者/共同第一作者及通讯作者/共同通讯作者发表SCI论文如下：

Huangqi Duan, Weimin Xia, Ding Xu, et al. Peripheral tuberculin purified protein derivative specific T cell immunoreactivity dynamics in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin instillation treatment. Front Oncol. 2022; 12: 927410.（共同通讯作者）

Qifeng Cao，Yu Wu，Wenbin Guan，et al. Diagnosis of Chronic Prostatitis by Noninvasive Methods in Elderly Patients with Benign Prostatic Hyperplasia in China. Andrologia. 2021; 53(6): e14055.（通讯作者）

Ding Xu, Zhongqing Yang, Jun Qi, et al. Early urinary continence recovery following retzius‑sparing robotic‑assistant radical prostatectomy with suprapubic catheter: a short‑term follow‑up outcome. World J Urol. 2021;  39(9):3251-3257.

Xiaoqiang Qian, Zhengqin Gu, Wenbin Guan, et al. Resveratrol could attenuate prostatic inflammation in rats with Oestradiol-induced chronic prostatitis. Andrologia. 2021; 53(4): e14004.（通讯作者）

Ding Xu, Xiaoling Lin, Xiaoqiang Qian, et al. SNPs of Metabolic Syndrome are Associated with Benign Prostatic Hyperplasia Development and Progression in Chinese Population. Current Bioinformatics. 2021; 16 (7): 901-908.

Lin Zhang, Yanyuan Wu, Ke Xu, et al. Compare the Clinical Application of Ureteroscopic Occluder and Stone Retrieval Basket During Holmium Laser Treatment for Upper Ureteral Calculi. Urol J. 2020; 17(5): 469-473.（共同通讯作者）

Yu Wu, Ding Xu, Haibo Shen, et al. The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a crosssectional study. Aging Male. 2020; 23(5): 841-846. （共同第一作者）

Xujun Sheng, Ding Xu, Yu Wu, et al. The risk factors of Urethrocutaneous fistula after hypospadias surgery in the youth population. BMC Urology. 2018;18(1): 64 （共同第一作者）

Ding Xu, Yu Wu, Haibo Shen, et al. High serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China. Aging Male. 2020; 23 (1): 1-6.

Qian X, Xu D, Liu H, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. Aging Male. 2017. 20(4): 250~256（共同第一作者）

Ding Xu, Jie Ding, Yunkai Zhu, et al. The new insight of prostate-specific antigen reduction during finasteride therapy in aging men. Aging Clin Exp Res. 2016; 28(6): 1237~1241.

Ding Jie, Ding Xu, Qifeng Cao, et al. Comparing theThe Risk Factors of Urethrocutaneous Fistula after Hypospadias Surgery in the youth population Efficacy of a Multimodular Flexible Ureteroscope With Its Conventional Counterpart in the Management of Renal Stones. Urology. 2015; 86(2): 224-229. (共同第一作者)

Jie Ding, Ding Xu, Chunwu Pan, et al. Current animal models of bladder cancer: Awareness of translatability (Review). Exp Ther Med. 2014; 8(3): 691–699. (共同第一作者)

Ding Xu, Yongjiang Yu, Yunkai Zhu, et al. A New Model Consists of Intravesical Prostatic Protrusion, Prostate Volume and Serum Prostatic-Specific Antigen in the Evaluation of Prostate Cancer, Pathol Oncol Res. 2014(20): 439-443.

社会学术团体兼职

上海市医学会泌尿外科分会尿控与整形学组组员

上海市排尿与盆底会诊中心 会诊专家

美国心脏病协会（AHA）基础生命支持及高级心血管生命支持 导师

主要研究方向

前列腺增生，慢性前列腺炎，膀胱肿瘤

近3年指导研究生的就业情况

无